Aesthetic Medical International Holdings Group Ltd. Received a Letter of Expected Delisting Determination From Nasdaq Staff and Requested a Hearing before the Nasdaq Hearings Panel

SHENZHEN, China, Dec. 06, 2022 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq:AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has requested a hearing before the Nasdaq Hearings Panel as the next step in the process in seeking an extension to satisfy the minimum $10 Million stockholders’ equity requirement set forth in Listing Rule 5450(b)(1)(A) for continued listing on The Nasdaq Capital Market. On December 1, 2022, the Company received the expected notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined to delist the Company’s common shares from Nasdaq unless the Company requests a hearing no later than 4:00 p.m. Eastern Time on December 8, 2022. The Company submitted the request for a hearing on December 4, 2022 Eastern Time. This request will ordinarily stay any further action by the Staff and the Company’s securities are expected to continue to be eligible to trade on Nasdaq at least pending the ultimate conclusion of the hearing process.

Read more at globenewswire.com